MEMike EmersonPhD, MScVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Mike Emerson | Management of Antiplatelet/DOAC DDIS (Pk/PD) - in Context of HIV, HCV, COVID Antiviral TherapyView Video
DCDario CattaneoPharmD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Dario Cattaneo | Case Presentation - Complex DDI caseView Video
EREmma RubensteinMD, MPHVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Emma Rubenstein | A Year of CAB/RPV Use, What Have We Learned in the Real WorldView Video
CWCatriona WaittMBChB, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Catriona Waitt | New(er) Antiretrovirals in Pregnancy and BreastfeedingView Video
CCCatherine ChappellMD, MScVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Catherine Chappell | Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in PregnancyView Video
LWLauren WalkerMBChB (Hons), PhD, MRCP (UK), PGCAP, FHEA, FBPhSVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Lauren Walker | The Use of AI in Clinical PharmacologyView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023Andrea Calcagno | Opening Lecture: News in Antiviral Pharmacology: A Year in ReviewView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023ANTIVIRAL PK 2023 - Promo VideoView Video
LWLaura WatersMD, FRCPVideoHIVRSV2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?CON Standpoint - Laura Waters, MD, FRCPView Video
JRJürgen RockstrohMDVideoHIVRSV2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?PRO Standpoint - Jürgen Rockstroh, MDView Video
JMLJosep M. LlibreMD, PhDVideoHIVRSVManaging HIV Patients with Limited Treatment Options - EU Series 2022 Second EditionManaging HIV Patients with Limited Treatment Options - 2nd EU Series, Spanish EditionView Video
CMCristina MussiniMDVideoHIVRSVManaging HIV Patients with Limited Treatment Options - EU Series 2022 Second EditionManaging HIV Patients with Limited Treatment Options - 2nd EU Series, Italian EditionView Video
